3,6,9,12,15-Pentaoxaoctadec-17-yn-1-amine

Catalog No.: 
ACYHIT512
CAS No.: 
1589522-46-2
Molecular Formula: 
C13H25NO5
Molecular Weight: 
275.35
3,6,9,12,15-Pentaoxaoctadec-17-yn-1-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$75.00In stockIn stock
5g95%$290.00In stockIn stock
25g95%$1407.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,6,9,12,15-Pentaoxaoctadec-17-yn-1-amine
IUPAC Name3,6,9,12,15-pentaoxaoctadec-17-yn-1-amine
MDL No.MFCD27977505
Molecular FormulaC13H25NO5
Molecular Weight275.35
SMILESNCCOCCOCCOCCOCCOCC#C
InChI KeyBLBTXXAWMPTQOK-UHFFFAOYSA-N
SynonymPropargyl-PEG5-amine;HC≡C-CH2-PEG6-NH2;Alkyne-PEG5-NH2;PROPARGYL-PEG5-NH2;3,6,9,12,15-Pentaoxaoctadec-17-yn-1-amine;Propargyl-PEG5-NH2/3,6,9,12,15-Pentaoxaoctadec-17-yn-1-amine;2-[2-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethoxy]ethoxy]ethanamine;NH2-PEG5-Propargyl
CAS No.1589522-46-2
PubChem CID77078244

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACYHIT512 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYHIT512 route product structure diagram
    ACYHIT5121589522-46-2In Stock
Inquiry

2. ACYHIT512 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYHIT512 route product structure diagram
    ACYHIT5121589522-46-2In Stock
Inquiry

3. ACYHIT512 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYHIT512 route product structure diagram
    ACYHIT5121589522-46-2In Stock
Inquiry

Comments (0)